Precision BioSearch expands C-suite team of SENISCA with COO and CDO appointments
Precision BioSearch partnered with SENISCA, an award-winning biotechnology company developing RNA based therapeutics to reverse cellular senescence and target age-related disease, building the C-suite team with the appointments of Dr. Sarah Cole as Chief Operating Officer and Dr. Tim Schmidt as Chief Development Officer.
For more information on the appointments, visit: SENISCA_Appointments.pdf
About SENISCA: SENISCA is an RNA therapeutics biotech spin-out from the University of Exeter, founded in 2020.
For more information about SENISCA, visit: www.senisca.com
Posted on : 23rd May 2023